Free tool

Rare disease stocks

We cover 17 companies grouped under the Rare disease theme. The median market value in the group is $12.95B. Across the group, the median move over the past trading day is −0.26%. Price change over the past year runs from −8.6% to +200.9% across the middle 80 percent of the group, with a median of +48.2%.

Other lists in this group

Table

17 of 268 companies match these filters.Clear filters

TickerCompanyMarket cap (USD)Size1Y returnNext report
VX1.DEVertex Pharmaceuticals Incorporated$139.82BLarge cap+41.64%Nov 2, 2026
VRTXVertex Pharmaceuticals Incorporated$138.63BLarge cap+40.66%Nov 2, 2026
DUL.DEAlnylam Pharmaceuticals, Inc.$32.28BLarge cap−10.21%Oct 29, 2026
ALNYAlnylam Pharmaceuticals, Inc.$32.12BLarge cap−47.38%Oct 29, 2026
INSMInsmed Incorporated$27.16BLarge cap−7.54%Oct 29, 2026
ROIVRoivant Sciences Ltd.$26.55BLarge cap+206.51%Nov 9, 2026
JAZZJazz Pharmaceuticals plc$16.89BLarge cap+100.35%Nov 4, 2026
BBIOBridgeBio Pharma, Inc.$15.52BLarge cap+60.05%Oct 28, 2026
CORTCorcept Therapeutics Incorporated$12.95BLarge cap+71.81%Nov 4, 2026
0JAV.LInsmed Incorporated$12.89BLarge cap−7.52%Oct 29, 2026
BMRNBioMarin Pharmaceutical Inc.$12.70BLarge cap+11.85%Oct 26, 2026
REC.MIRecordati Industria Chimica e Farmaceutica S.p.A.$12.57BLarge cap+1.80%Nov 10, 2026
ARWRArrowhead Pharmaceuticals, Inc.$12.52BLarge cap+308.99%Nov 24, 2026
CYTKCytokinetics, Incorporated$11.01BLarge cap+109.36%Nov 5, 2026
IONSIonis Pharmaceuticals, Inc.$10.56BLarge cap+48.21%Nov 4, 2026
KYMRKymera Therapeutics, Inc.$10.53BLarge cap+197.09%Nov 3, 2026
ABVX.PAABIVAX Société Anonyme$10.21BLarge cap+48.91%Sep 21, 2026

Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.

More ways to browse